StockWatch
·

Altimmune, Inc.

Ticker: 1326190

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-32.36-10.0712.2334.52Q2 FY2023Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q2 FY2023Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025
PeriodQ3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024Q3 FY2023Q2 FY2023
INCOME
Revenue0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01-97.2%0.36+3500.0%0.01
Total Income0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01-97.2%0.36+3500.0%0.01
EXPENSES
Expenditure20.86-9.0%22.93+5.1%21.82-11.9%24.77-7.4%26.75-0.2%26.80+17.0%22.90+27.2%18.01
Tax-0.680.000.000.000.00
PROFIT
PBT-19.01+14.2%-22.15-9.3%-20.26-20.67
Net Profit-19.01+14.2%-22.15-13.1%-19.58+14.3%-22.85+7.3%-24.64-1.0%-24.39-18.0%-20.67-28.7%-16.06
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.21+22.2%-0.27-3.8%-0.26+18.8%-0.32+8.6%-0.35-2.9%-0.34+12.8%-0.39-21.9%-0.32